about
Marijuana: current concepts(†)Anticancer mechanisms of cannabinoidsThe Cannabis Dilemma: A Review of Its Associated Risks and Clinical EfficacyCannabinoids as therapeutic agents in cancer: current status and future implicationsPreclinical and Clinical Assessment of Cannabinoids as Anti-Cancer AgentsCB2 receptor activation inhibits melanoma cell transmigration through the blood-brain barrier.A novel near-infrared fluorescence imaging probe that preferentially binds to cannabinoid receptors CB2R over CB1R.Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells.Suppression of invasion and metastasis in aggressive salivary cancer cells through targeted inhibition of ID1 gene expression.Critical appraisal of the potential use of cannabinoids in cancer management.CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders.Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.The evolving role of the endocannabinoid system in gynaecological cancer.Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo.Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis.Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.Design of p53-derived peptides with cytotoxicity on breast cancer.Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer.Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer.∆9-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer.A novel potential effective strategy for enhancing the antitumor immune response in breast cancer patients using a viable cancer cell-dendritic cell-based vaccine.Differentiation between fiber and drug types of hemp (Cannabis sativa L.) from a collection of wild and domesticated accessions
P2860
Q21090461-7331C122-6BBA-475C-8F34-D6CCC1C4DE76Q26750399-BAD3E3A5-C593-41FA-9B6B-F96FC87ACCB7Q26779350-61CE32B1-39EC-4200-94BF-4487964B9EEEQ26866298-F1B846FB-F797-4F5E-BA26-97D401606EF2Q28075903-03F1F4E7-2908-4289-86F8-D9FB6CD41EEEQ33755702-E0DCEED5-2F5C-4352-9F33-33E2E8CE26A1Q35591573-D6BEB3A7-33D9-4695-8074-634DC4B4A36FQ36120780-20B1F84F-EB55-471F-A89B-910572C39792Q36942471-FA9F4770-0FF1-4A9A-91E3-44AF198951C7Q37164208-ABF06760-E1DD-4890-8792-BA991A1A5DEEQ37386840-0BC9D58B-E82D-4E2F-99F5-D659C746E3E3Q38211378-5DD058D4-81B2-4D9F-8D56-FE6AD8A795B6Q38287745-4A97602D-1896-45B7-A3E8-E003AEF826D2Q38469671-FC87A003-5D0D-4DAF-9B6C-CC1F7F9C4983Q38660494-87EDAA01-B565-4C35-8D2B-C37DCCEBC9B9Q38808799-6D9256DA-B6C1-489B-B9F2-0B52793203F7Q38850929-A1873C21-CF4C-42D8-BEB3-BB529B6249C4Q38889500-31B25206-41C0-4616-96A8-35D6C7510ECBQ38994726-DDBFBFBD-8C67-4231-8642-27049A6B0EF7Q39150873-237DC89A-BB75-47B9-9133-272AE1EDFA95Q53814708-07EDA09B-AAA2-44B7-83C3-06E61E436A06Q55248912-2CA9AB9C-EDD3-406A-9994-F3423A90F8D1Q55387722-2B1858CD-D013-4235-B800-C5B8CB1A32A2Q57762483-9EEBE3AD-0310-4366-8C86-DE1816B985D3
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cannabinoids: a new hope for breast cancer therapy?
@en
type
label
Cannabinoids: a new hope for breast cancer therapy?
@en
prefLabel
Cannabinoids: a new hope for breast cancer therapy?
@en
P50
P1476
Cannabinoids: a new hope for breast cancer therapy?
@en
P2093
Clara Andradas
Manuel Guzmán
P304
P356
10.1016/J.CTRV.2012.06.005
P577
2012-07-07T00:00:00Z